Litcius/Paper detail

Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial

Barham K. Abu Dayyeh, Fateh Bazerbachi, Eric J. Vargas, Reem Z. Sharaiha, Christopher C. Thompson, Bradley C Thaemert, André Teixeira, Christopher G. Chapman, Vivek Kumbhari, Michael Ujiki, Jeanette E. Ahrens, Courtney N. Day, Andrés Acosta, Dilhana Badurdeen, Navtej Buttar, Matthew M. Clark, Laura Eaton, Omar M. Ghanem, Karen Grothe, Pichamol Jirapinyo, Todd Kellogg, Connie Klein, Manpreet S. Mundi, Andrew C. Storm, Angielyn R. Rivera, Todd Wilson, Manoel Galvão Neto, Natán Zundel, Erik B. Wilson

2022The Lancet315 citationsDOI

Topics & Concepts

MedicineClinical endpointWeight lossPopulationRandomized controlled trialIntention-to-treat analysisObesityInternal medicineProspective cohort studyClinical trialPhysical therapyEnvironmental healthBariatric Surgery and OutcomesBody Contouring and SurgeryCardiovascular Function and Risk Factors
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial | Litcius